Meeting
2014 ASCO Annual Meeting
Predictors of surgery types after neoadjuvant therapy for advanced stage breast cancer.
Authors
Jamila Alazhri
University of Miami Hospital, Miami, FL
Jamila Alazhri , Tulay Koru-Sengul , Feng Miao , Stacey L. Tannenbaum , Margaret M Byrne , Hattan Alghamdi , Dido Franceschi , Eli Avisar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1034)
DOI
10.1200/jco.2014.32.15_suppl.1034
Abstract #
1034
Poster Bd #
127
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy (NAC) in California, 1998-2012.
First Author: Irene Wapnir
Poster
2024 ASCO Genitourinary Cancers Symposium
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki-67.
First Author: Fengnian Zhao
Poster
2023 ASCO Quality Care Symposium
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ breast cancer from 2001-2016.
First Author: Erin Aiello Bowles
Poster
2023 ASCO Annual Meeting
Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial.
First Author: Nagi S. El Saghir